首页> 外文期刊>Frontiers in Public Health >Music Streaming Services as Adjunct Therapies for Depression, Anxiety, and Bipolar Symptoms: Convergence of Digital Technologies, Mobile Apps, Emotions, and Global Mental Health
【24h】

Music Streaming Services as Adjunct Therapies for Depression, Anxiety, and Bipolar Symptoms: Convergence of Digital Technologies, Mobile Apps, Emotions, and Global Mental Health

机译:音乐流媒体服务作为抑郁症,焦虑症和躁郁症的辅助疗法:数字技术,移动应用程序,情感和全球心理健康的融合

获取原文
       

摘要

Mobile technologies and music are recognized as opportunities to address mental health challenges (1–3), while clinical and economic benefits of mobile health (mHealth) are currently studied (4–6). Herein, we describe feasibility of repurposing music streaming services as therapies for affective disorders. According to the World Health Organization, there are 350 million people worldwide suffering from depression, and 60 million people living with bipolar disorder. Patients with affective disorders such as depression, anxiety, or bipolar spectrum, and their caregivers are challenged with managing disease symptoms, long-term treatments, and disabilities. Between 1990 and 2010, there has been a 41% increase in public health burden of mental, neurological, and substance use disorders, as measured by disability-adjusted life years (7). Depression accounts for 40.5% of total disability-adjusted life years among mental and substance-use disorders, whereas anxiety and bipolar disorder account for 14.6 and 7%, respectively (8). A long-term morbidity in bipolar spectrum disorders emphasizes the needs to improve treatments for depression (9). Treatments of affective disorders include mainly antidepressant, antipsychotic medications, and cognitive behavioral therapy (CBT). The efficacy of antidepressants for children and adolescent patients (10), medication adherence, and limited access to CBT in many countries continue to be a challenge for public health.
机译:移动技术和音乐被认为是应对精神健康挑战的机会(1-3),而目前正在研究移动健康(mHealth)的临床和经济利益(4-6)。在这里,我们描述了重新使用音乐流服务作为情感障碍疗法的可行性。根据世界卫生组织的数据,全世界有3.5亿人患有抑郁症,并且有6000万人患有躁郁症。患有情绪障碍(例如抑郁症,焦虑症或双相谱)的患者及其护理人员面临疾病症状,长期治疗和残疾的管理挑战。从1990年到2010年,通过残疾调整生命年来衡量,精神,神经系统和药物滥用疾病的公共卫生负担增加了41%(7)。在精神和药物滥用疾病中,抑郁症占总残疾调整生命年的40.5%,而焦虑症和躁郁症分别占14.6和7%(8)。双相谱疾病的长期发病率强调需要改善抑郁症的治疗方法(9)。情感障碍的治疗主要包括抗抑郁药,抗精神病药和认知行为疗法(CBT)。在许多国家,抗抑郁药对儿童和青少年患者的疗效(10),药物依从性以及获得CBT的机会有限,仍然是公共卫生面临的挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号